Aripiprazole (air-ee-PIP-ruh-zole) (marketed as Abilify ; also known as OPC-14597) was approved by the Food and Drug Administration (FDA) on November 15 , 2002 for the treatment of schizophrenia , the sixth atypical antipsychotic medication of its kind. más

Aripiprazole (air-ee-PIP-ruh-zole) (marketed as Abilify ; also known as OPC-14597) was approved by the Food and Drug Administration (FDA) on November 15 , 2002 for the treatment of schizophrenia , the sixth atypical antipsychotic medication of its kind. More recently it received FDA approval for the treatment of acute manic and mixed episodes associated with bipolar disorder , and as an adjunct for the treatment of depression . [ 1 ] Aripiprazole was developed by Otsuka in Japan; in the U.S., Otsuka America markets the drug jointly with Bristol-Myers Squibb . less